Neurology in Altamonte Springs, FL
5 verified neurology doctors in Altamonte Springs.
Neurologists diagnose and treat disorders of the brain, spinal cord, and nervous system, such as migraines, epilepsy, and stroke.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Dr. Steven Sable, DO
Neurology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Todd Hartley, MD
Neurology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Alicia Cabrera, MD
Neurology
CMS Open Payments· $1,344,592 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$1,344,592
Total received
223
Transactions
37
Paying companies
Top paying companies
Among the 22,669 neurology doctors we've analyzed, about 51% received any industry payment (median $640 among those who did). This doctor's total is higher than 100% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US neurology doctors.
Payments to Alicia Cabrera do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Shafiuddin Ahmed, MD
Neurology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Bernadette Nazario-Lopez, MD
Neurology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.